Tetsuro Yamane

Future Labo Co., Ltd. distributes cosmetics, skin-care products, and accessories through the internet. The company was founded on August 4, 2003 and is headquartered in Tokyo, Japan.

Pharma Foods Communication, Inc. engages in the pharmaceutical communications business. It deals with call center management, commissioning, and consulting services. The company was founded on August 24, 2015 and is headquartered in Fukuoka, Japan.

Founded in 1948, Meiji Yakuhin KK is a Japanese pharmaceutical company that supports the health of its customers for a bright and rich future. Part of Pharma Foods International Co., Ltd., the company is based in Tokyo, Japan. The company's mission is to promote the health and well-being of its customers. Meiji Yakuhin KK was acquired by Pharma Foods International Co., Ltd. on August 31, 2021 for $20.96 million.

Part of Seven & i Holdings Co., Ltd., Nissen Co., Ltd. is a Japanese company that operates online women's clothing stores. The company is based in Kyoto, Japan.

Part of Seven & i Holdings Co., Ltd., Kurashino Design, Inc. provides mail-order retail services. The company is based in Tokyo, Japan. Kurashino Design was acquired by Nissen Holdings Co. Ltd., a SUB of Seven & i Holdings Co., Ltd. from EDION Corp. on June 30, 2008.

Mail & eBusiness Logistics Service Co. Ltd. provides logistical and warehousing services. The company is headquartered in Kyoto, Japan.

Part of Kotobuki Realty Co., Ltd., Pronto Corp. Co. Ltd. offers a relaxing place to spend time any time of the day you choose. The company is based in Tokyo, Japan. Pronto provides information on menu (cafe time/bar type), store search, fc member and property introduction. The Japanese company also offers free wi-fi and a completely separate smoking section, and credit cards are accepted. The company's goal is to create a new place to relax, which can be called one culture. The company also introduces the history of Pronto Corporation.

SS Planning KK provides advertising, web production, and business consulting services. The private company is based in Tokyo, Japan.

Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland.